Tocilizumab in patients with severe COVID-19: a retrospective cohort study - The Lancet

Tocilizumab in patients with severe COVID-19: a retrospective cohort study  The Lancet

Comments

Popular posts from this blog

Epstein-Barr virus and autoimmune diseases

Chronic Lyme arthritis: A mystery solved?

Fibromyalgia — Latest Stories — Pain News Network